https://bsky.app/profile/pgrivasmdphd.bsky.socialhttps://bsky.app/profile/pgrivasmdphd.bsky.social/post/3lls25hxa2c2g1/ Best practices for 2L+ tx #MetastaticUrothelialCarcinoma 🧵 w🌟 @tiansterzhangmd.bsky.social & me ...assuming EV+P 1L ✅FGFR3 alts: THOR/erda 🎯Trop-2: sacituzumab govitecan 🏁HER2 IHC 3+: T-DXd Support by edu grants: Astellas, Gilead Sci, Merck, Seagen #CME from @bonumce.bsky.social ℹ️👇01 Apr 2025 23:37 +0000at://did:plc:3funffeia5bukch3mvgjxqlk/app.bsky.feed.post/3lls25hxa2c2ghttps://bsky.app/profile/pgrivasmdphd.bsky.social/post/3ldwoxnkbks2sCongratulations @n8pennell.bsky.social and all elected members @ascocancer.bsky.social [contains quote post or other embedded content]23 Dec 2024 00:39 +0000at://did:plc:3funffeia5bukch3mvgjxqlk/app.bsky.feed.post/3ldwoxnkbks2shttps://bsky.app/profile/pgrivasmdphd.bsky.social/post/3lcn2w5ymr22nStayed active during 17-hour flight from SEA->Singapore :-) Looking forward to present TROPiCS04 phase 3 trial data at #ESMOASIA on Dec 7 ~10am local time discussed by Dr. Friedlander @oncoalert.bsky.social @achoud72.bsky.social @erplimackmd.bsky.social @valdesan.bsky.social @fredhutch.bsky.social06 Dec 2024 11:21 +0000at://did:plc:3funffeia5bukch3mvgjxqlk/app.bsky.feed.post/3lcn2w5ymr22nhttps://bsky.app/profile/pgrivasmdphd.bsky.social/post/3lcbvgbbdgc23As we return from Thanksgiving Holidays we are grateful for everyone’s hard work & @ASCO mission to support providers & patients! Would like to remind active members to participate in @ASCO election-stellar candidates across all categories-Deadline: Dec 3rd 3pm EST https://society.asco.org/about-asco/asco-overview/asco-election?cmpid=ma_ascoorg_ascoelect_2025election_em_email___glob_110124_120324__learnmore_aware_text_&cid=DM18739&bid=42896128902 Dec 2024 00:44 +0000at://did:plc:3funffeia5bukch3mvgjxqlk/app.bsky.feed.post/3lcbvgbbdgc23